Boehm KM, Aherne EA, Ellenson L, Nikolovski I, Alghamdi M, Vázquez-García I, Zamarin D, Roche KLong, Liu Y, Patel D et al..  2022.  Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer.. Nat Cancer. 3(6):723-733.

Rao TDharma, Fernández-Tejada A, Axelrod A, Rosales N, Yan X, Thapi S, Wang A, Park KJ, Nemieboka B, Xiang J et al..  2017.  Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.. ACS Chem Biol. 12(8):2085-2096.

Vergote IB, Smith DC, Berger R, Kurzrock R, Vogelzang NJ, Sella A, Wheler J, Lee Y, Foster PG, Weitzman R et al..  2017.  A phase 2 randomised discontinuation trial of cabozantinib in patients with ovarian carcinoma.. Eur J Cancer. 83:229-236.

Sharma SKiran, Nemieboka B, Sala E, Lewis JS, Zeglis BM.  2016.  Molecular Imaging of Ovarian Cancer.. J Nucl Med. 57(6):827-33.